Press enter to see results or esc to cancel.

Tagworks Pharmaceuticals

Tagworks Pharmaceuticals is a precision therapy company and a pioneer of the Click-to-Release approach. Leveraging its patent-protected technology platform, it aims to create a new standard of care for patients suffering from severe diseases, including cancer. With operations in the Netherlands and the U.S., Tagworks is developing a pipeline of click-cleavable therapies. Its lead program, …

Continue Reading

T-knife Therapeutics

T-knife is a next-generation T-cell receptor (TCR) company developing a pipeline of therapeutics for solid tumor patients. The company leverages its proprietary humanized T-cell receptor (HuTCR) mouse platform to produce fully human TCRs, naturally selected in vivo for optimal affinity and specificity. T-knife is developing a pipeline of potential first/best-in-class TCR therapeutics against targets with …

Continue Reading


AM-Pharma is a clinical-stage biopharmaceutical company developing a treatment for sepsis-associated acute kidney injury (SA-AKI) – recombinant human alkaline phosphatase therapeutic. The company is focused on the successful execution of its Phase III REVIVAL pivotal trial while continuing to build an organization committed to using its insight and knowledge for other severe medical conditions, including …

Continue Reading